AKT1 and myocardial infarction: Pretreatment of animals with pharmacologic inhibitors of the PI3K/Akt signaling pathway, including either wortmannin or Ly294002, abrogated the observed reduction of myocardial infarct (MI) size in TLR4 deficient animals.